Similarly, in ovarian cancer specimens, the expression of COL11A1 is the highest in recurrent tumors compared to primary and metastatic tumors, suggesting that COL11A1 promotes tumor recurrence post chemotherapy [14,24]. This evidence concerns the gene COL11A1 and ovarian cancer.